A leading biotechnology startup pioneering a novel approach for extending healthspan by manipulating the functions of the thymus, Tolerance Bio, Inc., has secured $17.2 million in an oversubscribed seed investment round to advance the pioneering concept of developing medications for rare diseases. Founded in 2023 by Francisco Leon, Ph.D, the company focuses on extending the human
read more..